KDCT Workshops aim to foster an international exchange of ideas where we will brainstorm on trial design,
conduct, ethics, interpretation, approvability and implementation encompassing drugs, devices, biomarkers
and therapeutic strategies for kidney disease.
During our time together we have the opportunity to brainstorm on trial design, conduct, ethics,
interpretation, approvability and Implementation encompassing drugs, devices, biomarkers and therapeutic
strategies for kidney diseases.
Following the template of the CVCT workshop, the Kidney Disease Clinical Trialists (KDCT) Workshop is a high-
level think-tank, with an exceptional expert faculty. It involves a limited number of attendees and includes
distinguished nephrologists, clinical trialists, principal investigators and statisticians from academia, R&D
pharma, NIH, EMA and FDA.
